From the BBC World Service: Novo Nordisk, the company behind popular weight-loss and diabetes drugs like Ozempic and Wegovy, didn’t sell as many of those medications as expected in the second quarter. A lot has to do with supply issues and competition. Then, a Nobel Prize winner has been chosen as Bangladesh’s interim leader. And Spain’s tourism industry is hitting new records, but not everyone is thrilled with the surge in visitors.